ClinicalTrials.Veeva

Menu

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Enrolling

Conditions

Non-Hodgkin's Lymphoma
Hodgkin's Disease
Leukemia, Lymphocytic, Chronic
Lymphoproliferative Disorders

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Full description

  • Patients who participate will be asked to complete detailed family and medical history questionnaires initially, with a follow-up questionnaire every year.
  • Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of which can be done by mail.
  • Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study.
  • Patients will be given letters of invitation for their affected relatives to invite them to participate.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder; or families in which the individual has a lymphoproliferative disorder, and an unusual clustering of frequent or premature solid tumors is also observed.
  • Family members of the individual, either affected or unaffected with lymphoma, who are contacted by the individual and agree to participate in the study.
  • Deceased family members may be included in the study. Public records such as death certificates may be used to confirm the history. Consent for medical records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next of kin is spouse, offspring, parents and siblings. Archived tissue samples may be used for genetic research.
  • Age > 18 years

Exclusion criteria

  • Subjects without a family history of lymphoma

Trial design

1,500 participants in 3 patient groups

Next of Kin of deceased subj by lymphoma
Description:
Next of Kin of deceased subject by lymphoma
Subject unaffected by lymphoma
Description:
Subject unaffected by lymphoma
Subject affected by lymphoma
Description:
Subject affected by lymphoma

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Brown, MD PhD; Celeste Carey, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems